Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Palforzia Market Growth Potential: How Will Market Size Shift Through 2030?
The growth observed in the historic period resulted from several factors, including the increasing occurrence of peanut allergies, more precise diagnosis of food sensitivities, the clinical endorsement of oral immunotherapy treatments, heightened awareness among pediatric groups, and the establishment of more specialized allergy clinics.
The anticipated expansion during the forecast period stems from the increasing integration of disease-modifying allergy treatments, the growth of food allergy management initiatives, escalating investments in breakthroughs in immunotherapy, wider regulatory clearances for OIT products, and a heightened need for solutions reducing long-term allergy risks.
Key developments expected within the forecast timeframe encompass a greater uptake of oral immunotherapy for food allergies, a heightened emphasis on pediatric allergy treatments, the broadening of structured desensitization protocols, an escalating requirement for preventive anaphylaxis therapies, and improved oversight of treatment safety.
Get A Free Sample Report With In-Depth Market Insights:
Palforzia Market Growth Factors: What’s Supporting Expansion?
The rising occurrence of allergies is anticipated to drive the expansion of the palforiza market moving forward. An allergy represents an atypical immune reaction to generally harmless substances (allergens) such as pollen, dust, or specific foods, leading to symptoms like sneezing, rashes, or severe responses including anaphylaxis. The incidence of allergies is escalating due to factors like environmental shifts, pollution, genetic predisposition, and lifestyle elements such as diet, hygiene, and increased contact with allergens. Palforzia is utilized for oral immunotherapy to address peanut allergies by gradually desensitizing the immune system to peanut proteins, which helps lessen the intensity of allergic reactions, including anaphylaxis, caused by accidental exposure to peanuts. For instance, in August 2024, figures from the National Health Service (NHS England), a UK-based publicly funded healthcare system, showed that hospital admissions for individuals experiencing allergies and anaphylaxis increased to 32,300 in 2023-24, up from 25,702 in 2022-23. Hence, the increasing prevalence of peanut allergies is propelling the palforiza market.
Palforzia Market Segment Landscape: Which Areas Lead Development?
The palforzia market covered in this report is segmented –
1) By Clinical Indication: Peanut Allergy Treatment, Maintenance Phase Of Oral Immunotherapy (OIT), Peanut Allergy With a Risk Of Severe Reactions
2) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Healthcare Facilities
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
Palforzia Market Industry Trends: What’s Reshaping Demand?
Major companies within the Palforzia market are concentrating on creating innovative solutions, such as FDA-approved oral immunotherapy (OIT) treatments, to address the growing demand for safer, more effective, and clinically validated options for managing peanut allergies. Oral immunotherapy works by administering controlled, progressively increasing doses of an allergen to desensitize the immune system, offering a structured and long-term treatment strategy in contrast to traditional avoidance-based management, which does not alter the underlying immune response. For instance, in July 2024, Stallergenes Greer, a Switzerland-based company, obtained Food and Drug Administration (FDA) approval for the expansion of the pediatric indication for Palforzia (peanut (Arachis hypogaea) protein) oral immunotherapy, delivering allergy immunotherapy solutions globally. This product employs a gradual dose escalation process to desensitize individuals with peanut allergies and is provided in powder form for oral administration, with distinct dosage levels customized to the patient’s tolerance.
Palforzia Market Industry Leaders And Competitive Landscape
Major companies operating in the palforzia market are Stallergenes Greer International AG
View The Full Palforzia Market Report:
Palforzia Market Regional Analysis And Leading Geography
North America was the largest region in the palforzia market in 2025. The regions covered in the palforzia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
